Pure Bioscience Stock Price Prediction
| PURE Stock | USD 0.05 0.0001 0.20% |
Momentum 37
Sell Extended
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Pure Bioscience based on different types of headlines from major news networks to social media. Using Pure Bioscience hype-based prediction, you can estimate the value of Pure Bioscience from the perspective of Pure Bioscience response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Pure Bioscience. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Pure Bioscience to buy its otc stock at a price that has no basis in reality. In that case, they are not buying Pure because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell otc stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Pure Bioscience after-hype prediction price | USD 0.05 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Pure |
Pure Bioscience After-Hype Price Prediction Density Analysis
As far as predicting the price of Pure Bioscience at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Pure Bioscience or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Pure Bioscience, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Pure Bioscience Estimiated After-Hype Price Volatility
In the context of predicting Pure Bioscience's otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Pure Bioscience's historical news coverage. Pure Bioscience's after-hype downside and upside margins for the prediction period are 0.00 and 7.04, respectively. We have considered Pure Bioscience's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Pure Bioscience is out of control at this time. Analysis and calculation of next after-hype price of Pure Bioscience is based on 3 months time horizon.
Pure Bioscience OTC Stock Price Prediction Analysis
Have you ever been surprised when a price of a OTC Stock such as Pure Bioscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pure Bioscience backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pure Bioscience, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.43 | 6.99 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.05 | 0.05 | 0.20 |
|
Pure Bioscience Hype Timeline
Pure Bioscience is at this time traded for 0.05. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Pure is projected to increase in value after the next headline, with the price projected to jump to 0.05 or above. The average volatility of media hype impact on the company the price is insignificant. The price growth on the next news is projected to be 0.2%, whereas the daily expected return is at this time at -0.43%. The volatility of related hype on Pure Bioscience is about 0.0%, with the expected price after the next announcement by competition of 0.05. The company reported the previous year's revenue of 1.85 M. Net Loss for the year was (3.49 M) with profit before overhead, payroll, taxes, and interest of 1000 K. Given the investment horizon of 90 days the next projected press release will be within a week. Check out Pure Bioscience Basic Forecasting Models to cross-verify your projections.Pure Bioscience Related Hype Analysis
Having access to credible news sources related to Pure Bioscience's direct competition is more important than ever and may enhance your ability to predict Pure Bioscience's future price movements. Getting to know how Pure Bioscience's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Pure Bioscience may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| EXDW | Exceed World | 0.00 | 0 per month | 0.00 | (0.15) | 0.00 | 0.00 | 32.00 | |
| TNYBF | The Tinley Beverage | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| HERB | Yasheng Group | 0.00 | 0 per month | 13.12 | 0.04 | 44.48 | (36.17) | 107.51 | |
| DQWS | DSwiss Inc | 0.00 | 0 per month | 0.00 | 0.07 | 0.00 | 0.00 | 64.29 | |
| INDFY | Indofood Agri Resources | 0.00 | 0 per month | 0.00 | 0.09 | 0.00 | 0.00 | 18.39 | |
| NPRFF | Nepra Foods | 0.00 | 0 per month | 0.00 | (0.01) | 23.61 | (20.09) | 71.45 | |
| CAWW | CCA Industries | 0.00 | 0 per month | 2.64 | 0 | 5.08 | (5.71) | 26.74 | |
| NUVI | Emo Capital Corp | 0.00 | 0 per month | 0.00 | 0.15 | 71.64 | 0.00 | 209.87 | |
| LNLHF | LeanLife Health | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| HIGR | Hi Great Group Holding | 0.00 | 0 per month | 21.32 | 0.17 | 83.33 | (73.87) | 531.82 |
Pure Bioscience Additional Predictive Modules
Most predictive techniques to examine Pure price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pure using various technical indicators. When you analyze Pure charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Pure Bioscience Predictive Indicators
The successful prediction of Pure Bioscience stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pure Bioscience, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Pure Bioscience based on analysis of Pure Bioscience hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Pure Bioscience's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pure Bioscience's related companies.
Story Coverage note for Pure Bioscience
The number of cover stories for Pure Bioscience depends on current market conditions and Pure Bioscience's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pure Bioscience is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pure Bioscience's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Complementary Tools for Pure OTC Stock analysis
When running Pure Bioscience's price analysis, check to measure Pure Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pure Bioscience is operating at the current time. Most of Pure Bioscience's value examination focuses on studying past and present price action to predict the probability of Pure Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pure Bioscience's price. Additionally, you may evaluate how the addition of Pure Bioscience to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |